CountryOfPapers CountryOfPapers
Journal list Promote Sponsor
verified SJR 0,523 · Q2 • database Scopus / SJR indexed
Nanobiomedicine
United Kingdom · SAGE Publications Ltd
workspace_premium Q2 — Biotechnology visibility_off Double blind peer review lock_open Open Access

Nanobiomedicine

Nanobiomedicine is a journal indexed in SJR in Biotechnology and Biomedical Engineering with an H index of 18. It is an CC BY-NC Journal with a Double blind peer review review system The scope of the journal is focused on nanomedicine, nanotechnology, biology, bioengineering, drug delivery, nanotoxicology. It has an SJR impact factor of 0,523 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,523.

Publisher: SAGE Publications Ltd
Category: Biotechnology
Indexation: verifiedScopus / SJR
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,523 Q2
H-index 18
Acceptance rate pie_chart
45%
Source Acceptance_Rate
Time to publication hourglass_top
14 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
NPD Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR

SJR Impact

0,523

H-index

18

Docs (year)

0

Docs 3y

2

Total refs

0

Cites 3y

6

Citable 3y

2

Cites/Doc 2y

2

Ref/Doc

0.0

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs

What is the SJR of Nanobiomedicine?

Nanobiomedicine has an SJR of 0,523 (best quartile Q2) in the CountryOfPapers database.

What is the APC / publication cost?

Immediate OA APC is not available (NPD).

What is the acceptance rate?

The acceptance rate recorded for Nanobiomedicine is 45%.